for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Bristol-Myers and Eisai to jointly develop, market cancer drug

June 17 (Reuters) - Bristol-Myers Squibb Co and Eisai Co on Thursday entered into an agreement to jointly develop and market an experimental cancer drug.

Bristol Myers will pay $650 million to Eisai and up to $2.45 billion in milestone payments. (Reporting by Amruta Khandekar; Editing by Vinay Dwivedi)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up